Skip to Main Content

Advertisement

Skip Nav Destination

Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML

Blood Adv (2021) 5 (10): 2456–2466.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement